Long Covid in adults discharged from UK hospitals after Covid-19: A prospective, multicentre cohort study using the ISARIC WHO Clinical Characterisation Protocol
Louise Sigfrid(University of Oxford), J. T. Scott(MRC University of Glasgow Centre for Virus Research), Peter Openshaw(Imperial College London), Wei Shen Lim(Nottingham University Hospitals NHS Trust), Hayley Hardwick(University of Liverpool), Annemarie B Docherty(Edinburgh Royal Infirmary), J. Kenneth Baillie(NHS Lothian), Müge Çevik(University of St Andrews), Annelise Gillesen, Joanne McPeake(University of Glasgow), Peter Bannister(Brighton and Sussex Medical School), Margaret O’Hara, Alison Gummery(University of Liverpool), Piero Olliaro(University of Oxford), Malcolm G. Semple(University of Liverpool), Antonia Ho(University of Glasgow), Claire Hastie(Nvidia (United Kingdom)), Chloe Donohue(University of Liverpool), Thomas M Drake(University of Edinburgh), Colin Berry(University of Glasgow), Gail Carson, Claire E. Hastie(University of Glasgow), Laura Merson, Ewen M. Harrison(NHS Lothian), Daniel Munblit(Sechenov University), Clark D Russell(Centre for Inflammation Research), Nazir Lone(University of Edinburgh), Rebecca G. Spencer(University of Liverpool), Lance Turtle(University of Liverpool), Edwin C. Jesudason(NHS Lothian), Lynsey Goodwin(University of Liverpool), Cara Donegan(University of Liverpool), David J. Lowe(NHS Greater Glasgow and Clyde), Ellen Pauley(University of Edinburgh), Anna Casey(Brighton and Sussex Medical School)
Cited by 74
Related Papers
An atlas of active enhancers across human cell types and tissues
|Nature|2014|2.8k
Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial
|The Lancet|2020|2.6k
Association Between Administration of Systemic Corticosteroids and Mortality Among Critically Ill Patients With COVID-19
|JAMA|2020|2.4k
A minimal common outcome measure set for COVID-19 clinical research
|The Lancet Infectious Diseases|2020|1.8k